Dyne Therapeuticsinc Stock Buy Hold or Sell Recommendation
DYN Stock | USD 25.44 0.57 2.29% |
Considering the 90-day investment horizon and your above-average risk tolerance, our recommendation regarding Dyne TherapeuticsInc is 'Strong Hold'. Macroaxis provides Dyne TherapeuticsInc buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding DYN positions. The advice algorithm takes into account all of Dyne TherapeuticsInc's available fundamental, technical, and predictive indicators you will find on this site. Key drivers impacting Dyne TherapeuticsInc's buy or sell advice are summarized below:
Real Value 27.5 | Target Price 29.5 | Hype Value 26.49 | Market Value 25.44 |
A buy or sell recommendation provided by Macroaxis is an automated directive regarding whether to purchase or sell Dyne TherapeuticsInc given historical horizon and risk tolerance towards Dyne TherapeuticsInc. When Macroaxis issues a 'buy' or 'sell' recommendation for Dyne TherapeuticsInc, the advice is generated through an automated system that utilizes algorithms and statistical models.
Dyne |
Execute Dyne TherapeuticsInc Buy or Sell Advice
The Dyne recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Dyne TherapeuticsInc. Macroaxis does not own or have any residual interests in Dyne TherapeuticsInc or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Dyne TherapeuticsInc's advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
Strong Hold
Market Performance | Good | Details | |
Volatility | Not too volatile | Details | |
Hype Condition | Under hyped | Details | |
Current Valuation | Undervalued | Details | |
Odds Of Distress | Very Low | Details | |
Economic Sensitivity | Hyperactively responds to market trends | Details | |
Investor Sentiment | Alarmed | Details | |
Analyst Consensus | Strong Buy | Details | |
Financial Strenth (F Score) | Healthy | Details | |
Financial Leverage | Inapplicable | Details | |
Reporting Quality (M-Score) | Unlikely Manipulator | Details |
Dyne TherapeuticsInc Trading Alerts and Improvement Suggestions
Dyne TherapeuticsInc appears to be risky and price may revert if volatility continues | |
Reported Net Loss for the year was (235.94 M) with profit before taxes, overhead, and interest of 0. | |
Dyne TherapeuticsInc has about 291.84 M in cash with (188.16 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 5.64. | |
Over 87.0% of the company shares are held by institutions such as insurance companies | |
Latest headline from news.google.com: Dyne Therapeutics, Inc. Sees Large Increase in Short Interest - Defense World |
Dyne TherapeuticsInc Returns Distribution Density
The distribution of Dyne TherapeuticsInc's historical returns is an attempt to chart the uncertainty of Dyne TherapeuticsInc's future price movements. The chart of the probability distribution of Dyne TherapeuticsInc daily returns describes the distribution of returns around its average expected value. We use Dyne TherapeuticsInc price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Dyne TherapeuticsInc returns is essential to provide solid investment advice for Dyne TherapeuticsInc.
Mean Return | 0.75 | Value At Risk | -6.11 | Potential Upside | 6.42 | Standard Deviation | 4.47 |
Return Density |
Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Dyne TherapeuticsInc historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Dyne Stock Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Dyne TherapeuticsInc is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Dyne TherapeuticsInc backward and forwards among themselves. Dyne TherapeuticsInc's institutional investor refers to the entity that pools money to purchase Dyne TherapeuticsInc's securities or originates loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
Shares | Franklin Resources Inc | 2023-12-31 | 1.9 M | Logos Global Management Lp | 2023-12-31 | 1.9 M | Braidwell Lp | 2023-09-30 | 1.8 M | Wasatch Advisors Inc. | 0030-12-31 | 1.7 M | Tcg Crossover Management, Llc | 2023-12-31 | 1.7 M | Nantahala Capital Management, Llc | 2023-12-31 | 1.3 M | Fmr Inc | 2023-12-31 | 1.3 M | Artal Group S A | 2023-12-31 | 1.2 M | Vivo Capital, Llc | 2023-12-31 | 1 M | Fcpm Iii Services Bv | 2023-12-31 | 6.1 M | Mpm Asset Management, Llc | 2023-12-31 | 5 M |
Dyne TherapeuticsInc Cash Flow Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Change In Cash | 6.5M | 288.5M | (99.6M) | (29.1M) | (50.5M) | (53.0M) | |
Free Cash Flow | (13.5M) | (47.7M) | (123.2M) | (156.7M) | (188.9M) | (179.4M) | |
Depreciation | 271K | 700K | 1.1M | 1.7M | 2.5M | 2.3M | |
Other Non Cash Items | 1.3M | 514K | (746K) | 3.0M | 22.0M | 23.1M | |
Capital Expenditures | 1.6M | 1.2M | 3.6M | 3.1M | 729K | 692.6K | |
Net Income | (14.9M) | (59.4M) | (149.3M) | (168.1M) | (235.9M) | (247.7M) | |
End Period Cash Flow | 14.6M | 303.2M | 203.5M | 174.5M | 121.6M | 115.5M | |
Investments | (1.6M) | (45.7M) | (134.3M) | 87.2M | 76.4M | 80.2M | |
Change To Netincome | 1.3M | 7.1M | 19.4M | 18.2M | 20.9M | 21.9M |
Dyne TherapeuticsInc Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Dyne TherapeuticsInc or Biotechnology sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Dyne TherapeuticsInc's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Dyne stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over NYSE Composite | 0.49 | |
β | Beta against NYSE Composite | 3.06 | |
σ | Overall volatility | 4.49 | |
Ir | Information ratio | 0.15 |
Dyne TherapeuticsInc Volatility Alert
Dyne TherapeuticsInc shows above-average downside volatility for the selected time horizon. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Dyne TherapeuticsInc's stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact Dyne TherapeuticsInc's stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.Dyne TherapeuticsInc Fundamentals Vs Peers
Comparing Dyne TherapeuticsInc's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Dyne TherapeuticsInc's direct or indirect competition across all of the common fundamentals between Dyne TherapeuticsInc and the related equities. This way, we can detect undervalued stocks with similar characteristics as Dyne TherapeuticsInc or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Dyne TherapeuticsInc's fundamental indicators could also be used in its relative valuation, which is a method of valuing Dyne TherapeuticsInc by comparing valuation metrics with those of similar companies.
Better Than Average | Worse Than Average | Compare Dyne TherapeuticsInc to competition |
Fundamentals | Dyne TherapeuticsInc | Peer Average |
Return On Equity | -1.37 | -0.31 |
Return On Asset | -0.64 | -0.14 |
Current Valuation | 1.86 B | 16.62 B |
Shares Outstanding | 86.18 M | 571.82 M |
Shares Owned By Insiders | 0.55 % | 10.09 % |
Shares Owned By Institutions | 86.51 % | 39.21 % |
Number Of Shares Shorted | 8.08 M | 4.71 M |
Price To Earning | 35.58 X | 28.72 X |
Price To Book | 24.40 X | 9.51 X |
EBITDA | (239.7 M) | 3.9 B |
Net Income | (235.94 M) | 570.98 M |
Cash And Equivalents | 291.84 M | 2.7 B |
Cash Per Share | 5.64 X | 5.01 X |
Total Debt | 27.41 M | 5.32 B |
Debt To Equity | 0.11 % | 48.70 % |
Current Ratio | 11.63 X | 2.16 X |
Book Value Per Share | 1.49 X | 1.93 K |
Cash Flow From Operations | (188.16 M) | 971.22 M |
Short Ratio | 4.31 X | 4.00 X |
Earnings Per Share | (3.95) X | 3.12 X |
Price To Earnings To Growth | 0.19 X | 4.89 X |
Target Price | 37.75 | |
Number Of Employees | 141 | 18.84 K |
Beta | 0.95 | -0.15 |
Market Capitalization | 2.14 B | 19.03 B |
Total Asset | 165.08 M | 29.47 B |
Retained Earnings | (632.51 M) | 9.33 B |
Working Capital | 78.28 M | 1.48 B |
Current Asset | 1.93 B | 9.34 B |
Current Liabilities | 809 M | 7.9 B |
Net Asset | 165.08 M |
Note: Disposition of tradable shares by Cox John of Dyne TherapeuticsInc subject to Rule 16b-3 [view details]
Dyne TherapeuticsInc Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Dyne . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
Accumulation Distribution | 46012.17 | |||
Daily Balance Of Power | 0.38 | |||
Rate Of Daily Change | 1.02 | |||
Day Median Price | 25.58 | |||
Day Typical Price | 25.53 | |||
Price Action Indicator | 0.15 | |||
Period Momentum Indicator | 0.57 |
About Dyne TherapeuticsInc Buy or Sell Advice
When is the right time to buy or sell Dyne TherapeuticsInc? Buying financial instruments such as Dyne Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.2022 | 2023 | 2024 (projected) | Short and Long Term Debt Total | 30.5M | 27.4M | 26.0M | Total Assets | 306.3M | 165.1M | 156.8M |
Use Investing Ideas to Build Portfolios
In addition to having Dyne TherapeuticsInc in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Education Thematic Idea Now
Education
Companies involved in apprenticeship, education, tutoring, schooling, online universities, and other learning services. The Education theme has 41 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Education Theme or any other thematic opportunities.
View All Next | Launch |
Check out Dyne TherapeuticsInc Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. To learn how to invest in Dyne Stock, please use our How to Invest in Dyne TherapeuticsInc guide.You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.
Complementary Tools for Dyne Stock analysis
When running Dyne TherapeuticsInc's price analysis, check to measure Dyne TherapeuticsInc's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Dyne TherapeuticsInc is operating at the current time. Most of Dyne TherapeuticsInc's value examination focuses on studying past and present price action to predict the probability of Dyne TherapeuticsInc's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Dyne TherapeuticsInc's price. Additionally, you may evaluate how the addition of Dyne TherapeuticsInc to your portfolios can decrease your overall portfolio volatility.
Money Managers Screen money managers from public funds and ETFs managed around the world | |
Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
Commodity Directory Find actively traded commodities issued by global exchanges | |
Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. |
Is Dyne TherapeuticsInc's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Dyne TherapeuticsInc. If investors know Dyne will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Dyne TherapeuticsInc listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (3.95) | Return On Assets (0.64) | Return On Equity (1.37) |
The market value of Dyne TherapeuticsInc is measured differently than its book value, which is the value of Dyne that is recorded on the company's balance sheet. Investors also form their own opinion of Dyne TherapeuticsInc's value that differs from its market value or its book value, called intrinsic value, which is Dyne TherapeuticsInc's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Dyne TherapeuticsInc's market value can be influenced by many factors that don't directly affect Dyne TherapeuticsInc's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Dyne TherapeuticsInc's value and its price as these two are different measures arrived at by different means. Investors typically determine if Dyne TherapeuticsInc is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Dyne TherapeuticsInc's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.